SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043488
Filing Date
2021-08-11
Accepted
2021-08-11 16:44:44
Documents
56
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q arpo-10q_20210630.htm   iXBRL 10-Q 2049299
2 EX-31.1 arpo-ex311_9.htm EX-31.1 21755
3 EX-31.2 arpo-ex312_6.htm EX-31.2 22992
4 EX-32.1 arpo-ex321_7.htm EX-32.1 10533
5 EX-32.2 arpo-ex322_8.htm EX-32.2 11772
  Complete submission text file 0001564590-21-043488.txt   6355774

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA arpo-20210630.xsd EX-101.SCH 37175
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arpo-20210630_cal.xml EX-101.CAL 27578
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arpo-20210630_def.xml EX-101.DEF 108819
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arpo-20210630_lab.xml EX-101.LAB 310436
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arpo-20210630_pre.xml EX-101.PRE 229123
11 EXTRACTED XBRL INSTANCE DOCUMENT arpo-10q_20210630_htm.xml XML 1040464
Mailing Address 10663 LOVELAND-MADEIRA ROAD #168 LOVELAND OH 45140
Business Address 10663 LOVELAND-MADEIRA ROAD #168 LOVELAND OH 45140 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38560 | Film No.: 211164133
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences